Chromatin immunoprecipitation (ChIP) Sequencing Market Report 2026

Chromatin immunoprecipitation (ChIP) Sequencing Market Overview

• Chromatin immunoprecipitation (ChIP) Sequencing market size has reached to $15.48 billion in 2025 • Expected to grow to $29.02 billion in 2030 at a compound annual growth rate (CAGR) of 13.6% • Growth Driver: Prostate Cancer Prevalence Boosting Growth In The Chromatin Immunoprecipitation (Chip) Sequencing Market • Market Trend: Epigenica Launches EpiFinder™ Platform: A Game-Changer in High-Throughput ChIP Sequencing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Chromatin immunoprecipitation (ChIP) Sequencing Market?

Chromatin immunoprecipitation (ChIP) sequencing is a powerful molecular biology technique used to study the interactions between proteins and DNA within a cell. It provides insights into the binding patterns of specific proteins (often transcription factors or other chromatin-associated proteins) to the DNA in a genome-wide manner. The main types of chromatin immunoprecipitation (ChIP) sequencing are DNase-sequencing and faire-sequencing. DNase-sequencing, often referred to as DNase-seq, is a molecular biology technique used to study the accessibility of DNA within the genome. It is based on various technologies such as targeted sequencing and re-sequencing, whole genome sequencing, and whole exome sequencing used for pre-sequencing, sequencing, and data analysis. Its workflows as consumables and reagents, services, and others, by academic research institutes, clinical research institutes, hospitals and clinics, pharmaceuticals and biotechnology companies, and others.

What Is The Chromatin immunoprecipitation (ChIP) Sequencing Market Growth Forecast?

The chromatin immunoprecipitation (chip) sequencing market size is expected to see rapid growth in the next few years. It will grow to $29.02 billion in 2030 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to increasing investments in epigenomics research, rising adoption of AI-driven genomic analysis, expansion of precision medicine initiatives, growing demand for multi-omics integration, increasing use of cloud-based bioinformatics platforms. Major trends in the forecast period include increasing use of genome-wide protein-dna interaction mapping, rising adoption of high-throughput sequencing platforms, growing demand for epigenetics research tools, expansion of integrated bioinformatics analysis pipelines, enhanced focus on regulatory genomics studies.

Global Chromatin immunoprecipitation (ChIP) Sequencing Market Segmentation

1) By Type: DNase-Sequencing, FAIRE-Sequencing 2) By Technology: Targeted Sequencing And Re-Sequencing, Whole Genome Sequencing And Whole Exome Sequencing 3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis 4) By Application: Consumables And Reagents, Service, Other Applications 5) By End-User: Academic Research Institutes, Clinical Research Institutes, Hospitals And Clinics, Pharmaceuticals And Biotechnology Companies, Other End Users Subsegments: 1) By DNase-Sequencing: DNase I Hypersensitivity Mapping, DNase-Seq For Open Chromatin Regions 2) By FAIRE-Sequencing: Formaldehyde-Assisted Isolation Of Regulatory Elements (FAIRE), FAIRE-Seq For Active Regulatory Regions

What Is The Driver Of The Chromatin immunoprecipitation (ChIP) Sequencing Market?

The increasing prevalence of prostate cancer is expected to propel the growth of the chromatin immunoprecipitation (ChIP) sequencing market going forward. Prostate cancer is a type of cancer that develops in the prostate gland, a walnut-sized gland in men that produces fluid that helps semen. In prostate cancer research, ChIP-seq offers a comprehensive view of the molecular events driving the disease, providing critical information that can lead to a better understanding of its biology and the development of more targeted and effective therapeutic interventions. For instance, in January 2023, according to the American Cancer Society, a US-based cancer-fighting organization, in the US it is estimated that there were 288,300 new cases of prostate cancer and 34,700 deaths from prostate cancer in 2023. Therefore, the increasing prevalence of prostate cancer is driving the growth of the chromatin immunoprecipitation (ChIP) sequencing industry.

Key Players In The Global Chromatin immunoprecipitation (ChIP) Sequencing Market

Major companies operating in the chromatin immunoprecipitation (chip) sequencing market are F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc. , Becton Dickinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc. , PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Porvair Sciences Ltd. , Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., EpiCypher Inc.

Global Chromatin immunoprecipitation (ChIP) Sequencing Market Trends and Insights

Major companies in the chromatin immunoprecipitation (ChIP) sequencing market are focusing on innovative technologies, such as hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing) to enhance the efficiency and accuracy of epigenomic research, ultimately driving advancements in drug discovery and personalized medicine. hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing) is an advanced technology designed to enhance the study of epigenetic modifications across the genome. For instance, in June 2024, Epigenica, a Sweden-based life sciences technology company, launched its EpiFinder Platform, featuring patented hmqChIP-seq technology, which allows for high-throughput, multiplex quantitative analysis in epigenomic research. This innovative platform enables researchers to generate 192 genome-wide profiles simultaneously from up to 24 samples, streamlining large-scale experiments with unprecedented speed and cost-efficiency.

What Are Latest Mergers And Acquisitions In The Chromatin immunoprecipitation (ChIP) Sequencing Market?

In December 2023, Danaher Corporation, a US-based science and technology company, acquired Abcam plc, for an undisclosed amount. With this acquisition, Danaher aims to expand its life sciences portfolio, strengthen its position in the global research tools market, accelerate innovation in antibody and protein research solutions, and enhance its capabilities in enabling scientific discovery. Abcam plc, a UK-based life sciences company, that offers chromatin immunoprecipitation (ChIP) sequencing.

Regional Outlook

North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chromatin immunoprecipitation (ChIP) Sequencing Market?

The chromatin immunoprecipitation (ChIP) sequencing market consists of revenues earned by entities by providing services such as ChIP sample preparation, library preparation and sequencing, bioinformatics analysis, customization and consultation, data interpretation and reporting, and quality control, and assurance. The market value includes the value of related goods sold by the service provider or included within the service offering. The ChIP sequencing market also includes sales of ChIP kits, antibodies, DNA library preparation kits, sequencing kits, chromatin shearing equipment, and epigenetic modification kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chromatin immunoprecipitation (ChIP) Sequencing Market Report 2026?

The chromatin immunoprecipitation (chip) sequencing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chromatin immunoprecipitation (chip) sequencing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.